FDA advisory committee meeting to discuss NurOwn® for Amyotrophic Lateral Sclerosis scheduled for September 27, 2023
BrainStorm s Biologics License Application for NurOwn has a Prescription. -Today at 07:06 am- MarketScreener
NEW YORK, June 20, 2023 /PRNewswire/ BrainStorm Cell Therapeutics Inc. , a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced the appointment. | June 20, 2023